Personalized mRNA Cancer Vaccines Enter Trials to Prevent Tumor Recurrence

US researchers are testing a personalized mRNA-based vaccine designed to prevent tumor recurrence after initial cancer treatment. Early trial results suggest the approach can prime the immune system against patient-specific tumor antigens, representing a significant step toward individualized mRNA oncology therapies.